Our current efforts focuses on the development of clinical isolate collections to serve the needs of infectious disease researchers and drug and device development companies. Our specific work under this program includes the creation of the technology, processes and standards that are required for drug discovery and diagnostics.
- New collections of isolates designed and specifically characterized, to include phenotypic and full genome characterization
- Sourced from around the world, representing regions with high resistance development and isolates of significant current interest
- Contemporary and emerging pathogens and resistance types
- Product offerings and formats to facilitate studies of drug resistance, epidemiology and antimicrobial therapeutics
Click here to return to main ATCC-CTM page